Related references
Note: Only part of the references are listed.Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
S. Mallett et al.
BRITISH JOURNAL OF CANCER (2010)
A Need for Basic Research on Fluid-Based Early Detection Biomarkers
Katherine J. Martin et al.
CANCER RESEARCH (2010)
AACR-FDA-NCI Cancer Biomarkers Collaborative Consensus Report: Advancing the Use of Biomarkers in Cancer Drug Development
Samir N. Khleif et al.
CLINICAL CANCER RESEARCH (2010)
Sources of Bias in Specimens for Research About Molecular Markers for Cancer
David F. Ransohoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Envisioning the future of early anticancer drug development
Timothy A. Yap et al.
NATURE REVIEWS CANCER (2010)
Quality of reporting of diagnostic accuracy studies: No change since STARD statement publication - Before-and-after study
Nancy L. Wilczynski
RADIOLOGY (2008)
How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design
David F. Ransohoff
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
The quality of diagnostic accuracy studies since the STARD statement - Has it improved?
N. Smidt et al.
NEUROLOGY (2006)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
BRITISH JOURNAL OF CANCER (2005)
Share Paper
